H.C. Wainwright Virtual Event

December 6, 2021

9:00 AM – 3:00 PM (ET)

Unlocking the full potential of RNAi with world-class novel target identification: Regeneron Genomics and Alnylam’s RNAi Platform Collaboration Update

Event Sessions

SESSION ONE: 9:00 AM (ET)
REGENERON GENOMICS AND NASH


SESSION TWO: 11:15 AM (ET)
RNAi IN THE CNS AND ALN-APP PROGRAMS


SESSION THREE: 1:15 PM (ET)
COMPLEMENT-MEDIATED DISEASES

Who Should Attend?

Industry executives

Business development executives

Institutional investors

Private equity firms

Venture capitalists